Concomitant downregulation of IgH 3′ enhancer activity and c-myc expression in a plasmacytoma × fibroblast environment: Implications for dysregulation of translocated c-myc
- 28 February 1997
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 34 (2) , 97-107
- https://doi.org/10.1016/s0161-5890(97)00017-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Aberrant regulation of the IgH 3′ enhancer by c-myc in plasmacytoma cellsMolecular Immunology, 1995
- E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangementsCell, 1994
- Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3′ enhancerEuropean Journal of Immunology, 1994
- A class switch control region at the 3′ end of the immunoglobulin heavy chain locusCell, 1994
- Extinction of gene expression in somatic cell hybrids — a reflection of important regulatory mechanisms?Trends in Genetics, 1993
- E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins.Molecular and Cellular Biology, 1993
- Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival.Genes & Development, 1993
- The tissue-specific extinguisher locus TSE1 encodes a regulatory subunit of cAMP-Dependent protein kinaseCell, 1991
- The mouse IgH 3′‐enhancerEuropean Journal of Immunology, 1991
- Activation of the human beta-interferon gene requires an interferon-inducible factor.Molecular and Cellular Biology, 1986